LNTH · Lantheus Holdings, Inc.

Track LNTH — free

$99.96 +0.31 (+0.31%) At close · Oct 2

S&P 400 member Russell 2000 member Rebalance outlook locked

Market Cap

$6.51B

65.27M

Volume · Oct 2 714.69K Avg daily vol (3M) 1.34M

Up next

Next earnings call

Nov 6, 2026 Est · unconfirmed · in 5 wks

Latest filing: 10-Q

filed Aug 6, 2026

Q1 2026 earnings call transcript

call held May 7, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$1.56B

Trailing 12 months

Net income (TTM)

$275.31M

Trailing 12 months

Revenue growth YoY

+2.7%

Year over year

Operating margin

19.4%

Trailing 12 months

P / E (TTM)

23.9

Trailing earnings · reciprocal yield 4.2%

FCF yield

—

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

-4.0%

Year over year · fewer shares

Price change (1Y)

+89.7%

Trailing year

Short interest

6.2%

Latest settlement · 4.1 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Very Low

Market backdrop VIX 15.3 · calm Equity put/call 0.58

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +13%

above

Price vs 50-day avg −1%

below

RSI (14) 45

neutral

MACD trend Positive

52-week position 82%

mid-range

Momentum

relative strength

Very Strong

1-month return −1%

trailing

6-month return +22%

trailing

YTD return +50%

this year

Relative strength +10%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $101 › 200d $88 — 50d above 200d

Institutional flow Flat

1 of 469 funds reported for Sep 30 · net 0 sh shares

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

6.18% of float · ▼ -4.7% MoM · 4.1 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

469 holders — mid 3-yr range

Squeeze score 60

elevated · 0–100

Fundamentals

Strong

Revenue growth +4%

Y/Y

Gross margin 274%

contracting

EPS growth −22%

Y/Y

Valuation P/E 23.9

in line

Buyback $200.0M

remaining

Balance sheet $210.3M

net debt

Quant / Vol

risk profile

Very Low

Volatility 33%

annualized · 1-yr

Max drawdown −13%

past year

ATR 0.6%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Beat or met 8 of last 8

Latest guidance · from the 8-K filed May 7, 2026

FY 2026 Revenue · FY 2026 Initiated $1.4B – $1.45B

prior FY $1.54B midpoint −7.6% Y/Y

FY 2026 Adjusted fully diluted EPS · FY 2026 Non-GAAP Initiated $5.00 – $5.25

Guided vs delivered · last 8 settled

FY 2024 Revenue FY 2024

guided $1.5B – $1.52B

guided $1.5B – $1.52B $1.53B Beat +1.6%

Q2 FY 2024 Revenue Q2 FY 2024

guided $380M – $390M

guided $380M – $390M $394.09M Beat +2.4%

Revenue 1Q 2024

guided $347M – $355M

guided $347M – $355M $369.98M Beat +5.4%

FY 2023 Revenue FY 2023

guided $1.26B – $1.27B

guided $1.26B – $1.27B $1.3B Beat +2.7%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy

0 · 4 · 2

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+13% Bullish

Price vs 50-day avg

−1% Neutral

RSI (14)

45 Neutral

MACD trend

Positive Bullish

52-week position

82% Neutral

Market signals — smart money & positioning

Bullish · 1 of 6

Trend (MA cross) No cross

50d $101 › 200d $88 — 50d above 200d

Institutional flow Flat

1 of 469 funds reported for Sep 30 · net 0 sh shares

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

6.18% of float · ▼ -4.7% MoM · 4.1 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

469 holders — mid 3-yr range

Price context

position in its 52-week range

Range low $51 Now $100 · 82% Range high $111

vs 200-day avg +13% vs 50-day avg -1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Adjusted net income non-GAAP	200.75M	Six Months Ended June 30	—
Adjusted net income per share - diluted non-GAAP	$3.02	Six Months Ended June 30	—
Adjusted net income, as a percentage of revenues non-GAAP	26.2%	Six Months Ended June 30	—
Adjusted operating income non-GAAP	271.16M	Six Months Ended June 30	—
Adjusted operating income, as a percentage of revenues non-GAAP	35.4%	Six Months Ended June 30	—
Free cash flow non-GAAP	211.77M	Six Months Ended June 30	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
LNTH Lantheus Holdings, Inc. this stock	$6.51B	+50.2%	+3.6%	23.9	6.2%
TAK Takeda Pharmaceutical Co Ltd	$60.23B	+14.6%	—	—	0.1%
GALDY Galderma Group AG/ADR	$46.00B	-6.5%	—	—	0.0%
TEVA Teva Pharmaceutical Industries Ltd	$45.67B	+26.7%	+4.3%	64.3	2.7%
HLN Haleon plc	$40.72B	-13.0%	—	—	0.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders

Holders

469

% held: 116.1%
Reported: 1 of 469
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

490

View

Short & Settlement

Short Interest Falling

Shares short

4.0M

Days to cover: 4.1d
Change: -199.8K sh

View

Short Volume

Short vol %

63%

As of: Oct 2, 2026

Short Total

View

Fails to Deliver

FTD shares

Value: $100
As of: Aug 24, 2026

View

Off-Exchange

Off-exchange %

54.7%

Week of: Aug 24, 2026

Off-exch Lit

View

Smart Money

Congressional Trades Buy

Member

Gilbert Cisneros

Amount: $1.0K–$15.0K
Traded: Jan 28, 2025

View

Financials

Revenue (FY)

$1.5B

Net income (FY): $233.6M
EPS diluted: $3.41

View

Buybacks

Authorized

$400.0M

Remaining: $200.0M

Spent Remaining

View

Filings

SEC Filings

Latest

8-K

Filed: Oct 2, 2026
This year: 14

View

Proposed Sales

Value

$449.6K

Shares: 6.7K
Filed: Feb 2, 2026

View

Earnings & Events

Webcasts

Last webcast

Aug 6, 2026

View

Performance

	5D	20D	120D	MTD	YTD
LNTH	+0.2%	-1.0%	+22.4%	+0.4%	+50.2%
SPY	-0.2%	-0.5%	+12.2%	+0.9%	+12.9%
vs SPY	+0.4%	-0.6%	+10.2%	-0.5%	+37.3%

Capital returns

Buyback program · as of Jun 30, 2026

Authorized

$400.00M

Spent (derived)

$200.00M

Remaining

$200.00M

Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1521036 CUSIP 516544103 13F (30d) 21 filings 11 filers Visit website Investor relations

LNTH · Lantheus Holdings, Inc.

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns